Value Analysis Committee
Also known as: VAC, Value Analysis Team, VAT
The standing committee inside a hospital or health system that reviews a proposed purchase for clinical benefit, cost, and fit before it can move to contracting.
A Value Analysis Committee is the gate almost every meaningful clinical purchase passes through. It exists because a hospital cannot let each department buy independently: two surgeons preferring two different implant vendors doubles the inventory, the training, the contract overhead, and the error surface, with no clinical gain.
Membership is deliberately mixed. A typical committee seats supply chain, nursing, one or more physicians, finance, and often infection prevention, biomedical engineering, or pharmacy depending on what is being reviewed. Larger systems run several: a surgical VAC, a nursing products VAC, a capital equipment committee, and increasingly a separate technology or AI review body.
What the committee actually evaluates is narrower than most vendors expect. It is not primarily a technical review. It is a review of clinical evidence, total cost including the parts nobody quoted, disruption to existing workflow, and whether the organization already owns something that does most of the job.
The common vendor mistake is treating the committee as an audience for a product demonstration. By the time a request reaches a VAC, the committee is usually reading a written submission assembled by an internal requester, not watching a presentation. The vendor is frequently not in the room at all.
That has a practical consequence: the quality of the document your internal champion can assemble matters more than the quality of your pitch. See procurement-ready documentation for what that packet actually needs to contain.